Related Experiment Video
Updated: Aug 8, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Immunity and neurodegeneration: new concepts in multiple sclerosis]
P H Lalive1, M Schluep, M Chofflon
1Service de neurologie, Unité de neuroimmunologie, HUG, Genève. patrice.lalive@hcuge.ch
Abstract:
Multiple sclerosis is an autoimmune demyelinating disease of the central nervous system that leads to a progressive deterioration of the neurological functions. The concept of primary myelin and oligodendrocyte damage with axon sparing (axon-myelin dissociation) has been recently reconsidered with the demonstration that neuro-axonal lesions are an early phenomenon, linked to the inflammatory process, observed outside demyelinated areas, and correlated with the progression of the disease. Neurodegeneration in MS, long considered as a late process following recurrent episodes of demyelination, is now accepted as an early and major trigger of MS pathogenesis on which research should focus in the
Related Concept Videos
Multiple Sclerosis l: Introduction
Neurogenesis and Regeneration of Nervous Tissue

